Candida norvegensis: a fluconazole-resistant species

descriptionPublicationkeyboard_double_arrow_right Article 01 Jun 1997 English Publisher:American Society for MicrobiologyJournal:Antimicrobial Agents and Chemotherapy, volume 41, pages 1,375-1,376 (issn: 0066-4804, eissn: 1098-6596,

Copyright policy )

Authors: P, Sandven; K, Nilsen; A, Digranes; T, Tjade; J, Lassen;

doi: 10.1128/aac.41.6.1375

pmid: 9174202

pmc: PMC163918

Candida norvegensis: a fluconazole-resistant species

- Summary
- Subjects
- Metrics

Abstract

Candida norvegensis has been an unusual cause of infections in humans. In Norway this species was isolated from eight patients from 1990 to 1996 and was of probable pathogenic significance in four of them. All isolates were resistant to fluconazole. The same was true for two C. norvegensis isolates from before 1940, and it is therefore assumed that the fluconazole resistance is inherent.

Keywords

Adult, Aged, 80 and over, Antifungal Agents, Candidiasis, Flucytosine, Drug Resistance, Microbial, Microbial Sensitivity Tests, Middle Aged, Amphotericin B, Humans, Itraconazole, Fluconazole, Aged, Candida

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	35
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average